Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
2don MSN
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its ...
America’s FDA leadership has been making decisions based on ideology, not drug safety. It's time for a change of priorities.
Northstrive Biosciences has submitted a pre-Investigational New Drug, or pre-IND, meeting request to the FDA for EL-22, a novel myostatin asset ...
Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients 2 months ...
As the company prepares for its regulatory meetings, the healthcare community and investors ... it to finalize its OST-HER2 osteosarcoma trial payments and prepare for FDA approval. Additionally, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results